BioUtah COVID-19 Life Sciences Survey
March 17, 2020
TIME SENSITIVE – PLEASE TAKE SURVEY
Dear Members of Utah’s Life Sciences Community,
BioUtah is taking a multi-pronged approach to support our life sciences companies, industry workforce, and communities during the COVID-19 pandemic, including:
- Working directly with the Utah State Coronavirus Task Force to identify products and resources needed in the state
- Indentifing funding sources from state and federal governments to support emergency countermeasures and other responses
- Gaining a better understanding of how our companies are impacted and how BioUtah can provide assistance
We ask you to respond to a brief survey by Friday, March 20.
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize
